Inovio Pharmaceuticals, Inc.
INO· Nasdaq
Inovio Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · -2.92%
- Market cap
- $120.46M
- 103.4M shares
- Filings
- 1,012
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65,343 | reported | |
| FY 2024 | 2024-12-31 | $217,756 | reported | |
| FY 2023 | 2023-12-31 | $832,010 | reported | |
| FY 2022 | 2022-12-31 | $10,262,268 | reported | |
| FY 2021 | 2021-12-31 | $1,774,758 | reported | |
| FY 2020 | 2020-12-31 | $7,411,220 | reported | |
| FY 2019 | 2019-12-31 | $4,111,930 | reported | |
| FY 2018 | 2018-12-31 | $30,481,897 | reported | |
| FY 2017 | 2017-12-31 | $42,220,086 | reported | |
| FY 2016 | 2016-12-31 | $35,368,361 | reported | |
| FY 2015 | 2015-12-31 | $40,572,111 | reported | |
| FY 2014 | 2014-12-31 | $10,456,766 | reported |
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
